Hepcidin analogues and uses thereof
US12269856B2 · kind B2 · utility
0Cited by
28References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 28, 2023 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Sep 28, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, inter alia, to certain hepcidin peptide analogues, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.